Routine transferrin saturation measurement in liver clinic patients increases detection of hereditary haemochromatosis

Annals of Clinical Biochemistry

Volumn 40, Issue 5, 2003, Pages 521-527

  Poullis, A ^a   Moodie, S J ^a   Ang, L ^a   Finlayson, C J ^a   Levin, G E ^a   Maxwell, J D ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFERRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LIVER BIOPSY; MALE; MUTATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; SIDEROSIS;

BIOPSY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; MEMBRANE PROTEINS; MUTATION; PHENOTYPE; TRANSFERRIN;

EID: 0141629328     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456303322326434     Document Type: Article

References (39)

1. Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000; 33: 485-504
2. Williams R, Smith PM, Spicer EJ, Barry M, Sherlock S. Venesection therapy in idiopathic haemochromatosis. An analysis of 40 treated and 18 untreated patients. Q J Med 1969; 38: 1-16
3. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger B, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-19
4. The UK Haemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997; 41: 841-4
5. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-8
6. Poullis A, Moodie S, Ang L, Finlayson CJ, Maxwell DJ. H63D gene mutation is not associated with biochemical or hepatic iron overload in C282Y wild type gene carriers. Gut 2001; 49 (Suppl III): A2892
7. Burt MJ, George PM, Upton JD, et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 1998; 43: 830-6
8. Olynyk JK, Cullen DJ, Aquilia S, Rossi, E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341: 718-24
9. Ryan E, O'Keane C, Crowe J. Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis 1998; 24: 428-32
10. Moodie SJ, Ang L, Stenner JM, Finlayson C, Khotari A, Levin GE, Maxwell JD. Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers. Eur J Gastroenterol Hepatol 2002; 14: 223-9
11. MacSween RNM, Burt AD, Portman BC, Ishak KG, Scheur PJ, Anthony PP. Pathology of the Liver, 4 edn. Oxford: Churchill Livingstone, 2002
12. Worwood M. The laboratory assessment of iron status - an update. Clin Chim Acta 1997; 259: 3-23
13. Casaril M, Stanzial AM, Tognella P, Pantalena M, Capra F, Colombari R, Corrocher R. Role of iron load on fibrogenesis in chronic hepatitis C. Hepatogastroenterology 2000; 47: 220-5
14. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci 1982; 27: 909-16
15. Adams PC, Kertesz AE, McLaren CE, Barr R, Bamford A, Chakrabarti S. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors. Hepatology 2000; 31: 1160-4
16. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 2001; 358: 1405-9
17. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993; 328: 1616-20
18. McLaren CE, McLachlan GJ, Halliday JW, et al. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998; 114: 543-9
19. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988; 318: 1355-62
20. Borwein S, Ghent CN, Valberg LS, Diagnostic efficacy of screening tests for hereditary hemochromatosis. Can Med Assoc J 1984; 131: 895-901
21. Bassett ML, Halliday JW, Ferris RA, Powell LW. Daignosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology 1984; 87: 628-33
22. Lucotte G. Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol Dis 1998; 24: 433-8
23. Smith BN, Kantrowitz W, Grace ND, et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor? Hepatology 1997; 25: 1439-46
24. Jouanelle AM, Fergelot P, Raoul ML. Prevalence of the C282Y mutation in Brittany: penetrance of genetic haemochromatosis? [In French]. Annales de Genetique 1998; 41: 195-8
25. Nielson P, Carpentiero S, Fisher R. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Brit J Haem 1998; 103: 842-5
26. Adams PC. Population screening for haemochromatosis. Hepatology 1999; 29: 1324-7
27. McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 1999; 107: 30-7
28. Crawford DH, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998; 114: 1003-8
29. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998; 114: 319-23
30. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359: 211-8
31. Poullis A, Moodie SJ, Maxwell JD. Clinical haemochromatosis in HFE carriers. Lancet 2002; 360: 411-2
32. Ryan E, Byrnes V, Coughlan B, Flanagan AM, Barrett S, O'Keane JC, Crowe J. Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration? Gut 2002; 51: 108-12
33. Asberg A, Hveem K, Thorstensen K, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001; 36: 1108-15
34. Willis G, Wimperis JZ, Lonsdale R, Fellows IW, Watson MA, Skipper LM, Jennings BA. Incidence of liver disease in people with HFE mutations. Gut 2000; 46: 401-4
35. Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996; 23: 724-7
36. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002; 122: 281-9
37. Olynyk J, Hall P, Reed W, Williams P, Kerr R, Mackinnon M. A long-term study of the interaction between iron and alcohol in an animal model of iron overload. J Hepatol 1995; 22: 671-6
38. Olynyk J, Hall P, Ahern M, Kwiatek R, Mackinnon M. Screening for genetic haemochromatosis in a rheumatology clinic. Aust N Z J Med 1994; 24: 22-5
39. Willis G, Scott DG, Jennings BA, Smith K, Bukhari M, Wimperis JZ. HFE mutations in an inflammatory arthritis population. Rheumatology 2002; 41: 176-9